PCSK9: A New Target for Lipid-Lowering Therapy
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a crucial protein in low density lipoprotein cholesterol (LDL-C) metabolism. It binds the low density lipoprotein receptor (LDLR) and returns the LDLR to degradation in the lysosome and thereby raises the plasma levels of LDL-C. Gain-of-functi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Prince of Songkla University
2014-04-01
|
| Series: | Journal of Health Science and Medical Research (JHSMR) |
| Subjects: | |
| Online Access: | https://www.jhsmr.org/index.php/jhsmr/article/view/208 |